In these GC-resistant, MR-positive MM1.R cells, the myeloma cell killing effect of Spi was also substantially larger than in U-266 cells (Fig. 3C, D), which express low levels of MR, suggesting that Spi acts at least in part in an MR-dependent way. This evidence concerns the gene NR3C2 and plasma cell myeloma.